Insider · CIK 0001357522

Thompson Peter A.

CIK 0001357522 Name as filed on the most recent filing

Filed as Thompson Peter A. (53)· Thompson Peter A (2)

111 transaction lines · from 55 filings · filed 2006-10-19 to 2026-07-09 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

111 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2021-03-30 P, Open-market purchase Edgewise Therapeutics, Inc.EWTX 2 lines 5,750,000, acquired Open Form 4 filing 0001209191-21-023868
2021-02-17 P, Open-market purchase Decibel Therapeutics, Inc.DBTX 2 lines 29,999,988, acquired Open Form 4 filing 0000899243-21-007438
2021-02-17 P, Open-market purchase Corvus Pharmaceuticals, Inc.CRVS 4,499,999, acquired Open Form 4 filing 0000947871-21-000248
2020-12-28 S, Open-market sale Alpine Immune Sciences, Inc.ALPN 8,550,000, disposed Open Form 4 filing 0000947871-20-000980
2020-12-08 P, Open-market purchase Silverback Therapeutics, Inc.SBTX 2 lines 25,000,017, acquired Open Form 4 filing 0001209191-20-062390
2020-09-25 P, Open-market purchase PMV Pharmaceuticals, Inc.PMVP 2 lines 17,100,000, acquired Open Form 4 filing 0001209191-20-052337
2019-08-06 P, Open-market purchase Corvus Pharmaceuticals, Inc.CRVS 500,723, acquired Open Form 4 filing 0000947871-19-000572
2019-07-01 P, Open-market purchase Corvus Pharmaceuticals, Inc.CRVS 231,640, acquired Open Form 4 filing 0000947871-19-000487
2019-06-28 P, Open-market purchase Corvus Pharmaceuticals, Inc.CRVS 2,102,462, acquired Open Form 4 filing 0000947871-19-000487
2019-06-27 P, Open-market purchase Corvus Pharmaceuticals, Inc.CRVS 109,963, acquired Open Form 4 filing 0000947871-19-000487
2019-06-24 P, Open-market purchase Prevail Therapeutics Inc.PRVL 14,999,984, acquired Open Form 4 filing 0001209191-19-039130
2019-01-18 P, Open-market purchase Alpine Immune Sciences, Inc.ALPN 1,999,997, acquired Open Form 4 filing 0000947871-19-000044
2018-12-11 P, Open-market purchase Synthorx, Inc.THOR 14,999,996, acquired Open Form 4 filing 0001209191-18-062519
2018-06-06 S, Open-market sale Adaptimmune Therapeutics PLCADAP 21,584, disposed Open Form 4 filing 0000947871-18-000493
2018-06-04 S, Open-market sale Adaptimmune Therapeutics PLCADAP 232,047, disposed Open Form 4 filing 0000947871-18-000493
2018-06-01 S, Open-market sale Adaptimmune Therapeutics PLCADAP 674,500, disposed Open Form 4 filing 0000947871-18-000483
2018-05-30 S, Open-market sale Adaptimmune Therapeutics PLCADAP 1,635,920, disposed Open Form 4 filing 0000947871-18-000483
2018-05-14 S, Open-market sale Adaptimmune Therapeutics PLCADAP 139,050, disposed Open Form 4 filing 0000947871-18-000423
2018-03-29 S, Open-market sale Adaptimmune Therapeutics PLCADAP 368,764, disposed Open Form 4 filing 0000947871-18-000308
2018-03-27 S, Open-market sale Adaptimmune Therapeutics PLCADAP 11,684,966, disposed Open Form 4 filing 0000947871-18-000308
2018-03-12 P, Open-market purchase Corvus Pharmaceuticals, Inc.CRVS 4,999,998, acquired Open Form 4 filing 0000947871-18-000245
2017-03-27 P, Open-market purchase Adaptimmune Therapeutics PLCADAP 4,999,999, acquired Open Form 4 filing 0000947871-17-000256
2016-06-24 P, Open-market purchase Corvus Pharmaceuticals, Inc.CRVS 11,691, acquired Open Form 4 filing 0000947871-16-001307
2016-06-23 P, Open-market purchase Corvus Pharmaceuticals, Inc.CRVS 1,292, acquired Open Form 4 filing 0000947871-16-001307
2016-06-21 P, Open-market purchase Corvus Pharmaceuticals, Inc.CRVS 335,688, acquired Open Form 4 filing 0000947871-16-001290
2016-06-17 P, Open-market purchase Corvus Pharmaceuticals, Inc.CRVS 153,504, acquired Open Form 4 filing 0000947871-16-001290
2016-06-16 P, Open-market purchase Response Biomedical CorpRBM 3 lines 500,000, acquired Open Form 4 filing 0000947871-16-001284
2016-06-16 P, Open-market purchase Corvus Pharmaceuticals, Inc.CRVS 60,200, acquired Open Form 4 filing 0000947871-16-001267
2016-06-15 P, Open-market purchase Corvus Pharmaceuticals, Inc.CRVS 59,700, acquired Open Form 4 filing 0000947871-16-001267
2016-06-14 P, Open-market purchase Corvus Pharmaceuticals, Inc.CRVS 127,100, acquired Open Form 4 filing 0000947871-16-001267
2016-06-10 P, Open-market purchase Corvus Pharmaceuticals, Inc.CRVS 259,600, acquired Open Form 4 filing 0000947871-16-001259
2016-06-09 P, Open-market purchase Corvus Pharmaceuticals, Inc.CRVS 388,500, acquired Open Form 4 filing 0000947871-16-001259
2016-05-24 P, Open-market purchase Adaptimmune Therapeutics PLCADAP 5,432,832, acquired Open Form 4 filing 0000947871-16-001218
2016-05-23 P, Open-market purchase Adaptimmune Therapeutics PLCADAP 12,392,640, acquired Open Form 4 filing 0000947871-16-001218
2016-05-20 P, Open-market purchase Adaptimmune Therapeutics PLCADAP 24,096, acquired Open Form 4 filing 0000947871-16-001218
2016-05-20 P, Open-market purchase Corvus Pharmaceuticals, Inc.CRVS 61,732, acquired Open Form 4 filing 0000947871-16-001212
2016-05-19 P, Open-market purchase Corvus Pharmaceuticals, Inc.CRVS 2 lines 31,525, acquired Open Form 4 filing 0000947871-16-001204
2016-05-18 P, Open-market purchase Corvus Pharmaceuticals, Inc.CRVS 48,510, acquired Open Form 4 filing 0000947871-16-001204
2016-03-29 P, Open-market purchase Corvus Pharmaceuticals, Inc.CRVS 8,250,000, acquired Open Form 4 filing 0001104659-16-108207
2015-07-21 P, Open-market purchase ProNAi Therapeutics IncDNAI 2,975,000, acquired Open Form 4 filing 0001209191-15-061937
2007-11-19 P, Open-market purchase Trubion Pharmaceuticals, IncTRBN 25,588, acquired Open Form 4 filing 0001209191-07-065469
2007-11-19 P, Open-market purchase Trubion Pharmaceuticals, IncTRBN 5,934, acquired Open Form 4 filing 0001209191-07-065469
2007-11-19 P, Open-market purchase Trubion Pharmaceuticals, IncTRBN 3,963, acquired Open Form 4 filing 0001209191-07-065469

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 64
  • Open-market sale 47
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Thompson Peter A., insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001357522

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.